Subscribe To
LABD / LABU And LABD: Another Attractive Double-Short Pairs Trade
LABD News
By Seeking Alpha
September 29, 2023
LABU And LABD: Another Attractive Double-Short Pairs Trade
Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both asse more_horizontal
By Seeking Alpha
July 21, 2023
LABD: 3X Leveraged Inverse Fund In Biotechnology Sector Is Best Avoided
Direxion Daily S&P Biotech Bear 3X Shares ETF failed to generate decent yield & price growth over the past 90 months. I don't foresee this fund genera more_horizontal
By Zacks Investment Research
March 27, 2023
5 Best Leveraged ETFs of Last Week
Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street. more_horizontal
By Seeking Alpha
November 3, 2022
The Sell Rating Of LABD Is Reaffirmed
Since July 8 when I rated LABD a SELL, the underlying biotechnology index has moved very little up or down; LABD declined 25.22%. The biotechnology se more_horizontal
By Seeking Alpha
March 18, 2022
LABD: 3X Leveraged Investments Not Suitable For Long Term
3X inverse derivative investments are extremely volatile and risky. more_horizontal